Login
$IDXX
$700.65 +$0.00 (0.0%) After hours

$IDXX SEC Filings

Filed On Filing
12 Nov 2026 Form 4: Fennell George, Executive Vice President

Received 1,749 shares by exercise or conversion ($300K)

05 Nov 2026 Form 4: Underberg Sharon E., EVP, GC & Corporate Secretary

Received 8,906 shares by exercise or conversion ($2.57M) · Sold 8,906 shares ($6.13M)

05 Nov 2026 Form 4: Mazelsky Jonathan Jay, Director

Received 25,140 shares by exercise or conversion ($4.48M) · Sold 25,140 shares ($17.7M)

05 Nov 2026 Form 4: Lane Michael, Executive Vice President

Sold 3,978.944 shares ($2.74M)

05 Nov 2026 Form 4: Junius Daniel M, Director

Sold 1,200 shares ($845K)

05 Nov 2026 144/A
04 Nov 2026 144
04 Nov 2026 144
04 Nov 2026 144
04 Nov 2026 144
03 Nov 2026 Form 4: Hooley Joseph L, Director

Received 48 shares as a grant or award ($26.5K)

02 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition

Achieves third quarter revenue growth of 10% as reported and organic and CAG Diagnostics recurring revenue growth of 11% as reported and organic.

30 Oct 2026 SCHEDULE 13G
09 Sep 2026 Form 4: Kingsley Lawrence D, Director

Received 2,203 shares by exercise or conversion ($252K) · Sold 2,203 shares ($1.17M)

04 Sep 2026 144
24 Aug 2026 Form 4: Emerson Andrew, EVP, CFO and Treasurer

Received 265 shares by exercise or conversion ($47.2K) · Gave up 86 shares to cover exercise price or tax

04 Aug 2026 10-Q
04 Aug 2026 8-K: Results of Operations and Financial Condition

Achieves second quarter revenue growth of 10% as reported and 9% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic.

03 Aug 2026 Form 4: Hooley Joseph L, Director

Received 49 shares as a grant or award ($27.4K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support